Aliment Pharmacol Ther

1. LE COSQUER G, Laharie D
   Editorial: Ulcerative Colitis Management in the Biologic Era-Data From the English Healthcare Databases.
   Aliment Pharmacol Ther. 2025 Sep 11. doi: 10.1111/apt.70346.
   

   >> Share

   
   
2. SINGH M, Grover M, Petrik M
   Letter: Multidisciplinary Approach for Inflammatory Bowel Disease to Promote Value-Based Care.
   Aliment Pharmacol Ther. 2025 Sep 9. doi: 10.1111/apt.70369.
   

   >> Share

   
   
3. COUCH J, Thomas K, Card TR, Humes DJ, et al
   Editorial: Ulcerative Colitis Management in the Biologic Era-Data From the English Healthcare Databases. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Sep 8. doi: 10.1111/apt.70362.
   

   >> Share

   
   
4. DALAL RS, Clarke LM, Cabral HJ, Carlin AD, et al
   Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series.
   Aliment Pharmacol Ther. 2025 Jul 24. doi: 10.1111/apt.70298.
   

   >> Share

   
   
5. ELFORD AT, Constantine-Cooke N, Jenkinson PW, Gros B, et al
   Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland.
   Aliment Pharmacol Ther. 2025;62:699-709.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

6. WANG Z, Hoffert Y, Zhang W, Kantasiripitak W, et al
   Infliximab and ustekinumab clearance better predict endoscopic outcomes than trough concentrations in Crohn's disease.
   Clin Gastroenterol Hepatol. 2025 Sep 7:S1542-3565(25)00750.
   

   >> Share

   
   

   
   Clin Res Hepatol Gastroenterol

7. TATOUR M, Baker FA, Saadi T, Hazzan R, et al
   Long-Term Risk of Inflammatory Bowel Disease in Autoimmune Hepatitis: over a 20-Year Population-Based Study.
   Clin Res Hepatol Gastroenterol. 2025 Sep 6:102682.
   

   >> Share

   
   

   
   Dig Dis Sci

8. YANG X, Xie F
   Clinical Insights on "Tolerability and Effectiveness of Glucagon?Like Peptide?1 Receptor Agonists in Patients with Inflammatory Bowel Disease".
   Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09349.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

9. PARKASH N, Keung C, Bell SJ, Moore GT, et al
   Evaluating the completeness of postoperative endoscopic recurrence assessment in Crohn's disease patients with Kono-S anastomoses.
   Eur J Gastroenterol Hepatol. 2025 Aug 25. doi: 10.1097/MEG.0000000000003063.
   

   >> Share

   
   
10. LU G, Sun J, Du H
    Feasibility and Preliminary Efficacy of combined home-based fecal calprotectin self-testing and therapeutic drug monitoring-guided intervention in Patients with moderate-to-severe inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2025 Aug 15. doi: 10.1097/MEG.0000000000003061.
    

    >> Share

    
    
11. QIN Y, He C, Zhong N, Guo L, et al
    Exploring the molecular mechanism of Crohn's disease and rheumatoid arthritis: a bioinformatics and functional analysis approach.
    Eur J Gastroenterol Hepatol. 2025 Sep 8. doi: 10.1097/MEG.0000000000003068.
    

    >> Share

    
    
12. TAMIMI TA, Abu-Farsakh N, AlRyalat SA, Obeidat K, et al
    Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2025 Sep 5. doi: 10.1097/MEG.0000000000003067.
    

    >> Share

    
    

    
    Gastroenterol Hepatol

13. ROCHE PC, Casanovas-Marsal JO, Lopez SG, Lidon RV, et al
    TRANSLATION AND PSYCHOMETRIC EVALUATION OF THE SPANISH VERSION OF THE INFLAMMATORY BOWEL DISEASE KNOWLEDGE (IBD-KNOW) QUESTIONNAIRE.
    Gastroenterol Hepatol. 2025 Sep 9:502576. doi: 10.1016/j.gastrohep.2025.502576.
    

    >> Share

    
    
14. LOPEZ-CALLEJA AM, Cauce BL, Colomino MI, Martin BV, et al
    Fatigue in patients with Inflammatory Bowel Disease: a descriptive cross-sectional study.
    Gastroenterol Hepatol. 2025 Sep 7:502557. doi: 10.1016/j.gastrohep.2025.502557.
    

    >> Share

    
    

    
    Gut

15. ASHTON JJ, Green Z, Beattie RM
    British Society of Gastroenterology adult guidelines on inflammatory bowel disease: what can we learn for children and young people?
    Gut. 2025 Sep 12:gutjnl-2025-336739. doi: 10.1136/gutjnl-2025-336739.
    

    >> Share

    
    
16. HAZIME H, Ducasa GM, Santander AM, Brito N, et al
    DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis.
    Gut. 2025;74:1589-1601.
    

    >> Share

    
    
17. GONZALEZ-ACERA M, Patankar JV, Erkert L, Cineus R, et al
    Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD.
    Gut. 2025;74:1602-1615.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

18. BOHAR B, Thomas JP, Liu Y, Brooks-Warburton J, et al
    Patient-Specific Regulatory Network Rewiring in Inflammatory Bowel Disease: How Genetic Polymorphisms Divert Incoming Signals and Contribute to Disease Pathogenesis.
    Inflamm Bowel Dis. 2025 Sep 7:izaf173. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

19. WILS P, Altwegg R, Buisson A, Vuitton L, et al
    Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
    J Crohns Colitis. 2025 Sep 10:jjaf166. doi: 10.1093.
    

    >> Share

    
    
20. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
    Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2025;19:jjaf129.
    

    >> Share

    
    

    
    Mediators Inflamm

21. LI P, Hu H, Yang L, Zhong L, et al
    Multiomics Integration and Machine Learning Reveal Colony Stimulating Factor 3 Receptor as a Key Gene and Therapeutic Target in Crohn's Disease.
    Mediators Inflamm. 2025;2025:1619237.
    

    >> Share

    
    

    
    PLoS One

22. ZHAO J, Miao D, Xiao T, Yang T, et al
    Global disease burden of inflammatory bowel disease in women and women of childbearing age from 1990 to 2021 and its prediction to 2040.
    PLoS One. 2025;20:e0331034.
    

    >> Share

    
    

    
    Scand J Gastroenterol

23. HJELLE H, Myklebust TA, Granlund AVB, Ostvik AE, et al
    Changes in prevalence and incidence of inflammatory bowel disease over 30 years: a population-based cohort study, the HUNT study.
    Scand J Gastroenterol. 2025 Sep 12:1-11. doi: 10.1080/00365521.2025.2555920.
    

    >> Share

    
    
24. HAANAPPEL AEG, van Tieghem de Ten Berghe C, Ali M, Wolthuis AM, et al
    Predictive value of postoperative CRP levels for endoscopic recurrence in patients with Crohn's disease undergoing ileocolic resection.
    Scand J Gastroenterol. 2025 Sep 10:1-9. doi: 10.1080/00365521.2025.2553885.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share